A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Etravirine Impurity 22 - Request Quote

Picture of Etravirine Impurity 22

Etravirine Impurity 22

SZ CAT No:SZ-E038034
CAS No
NA
Mol.F.
C25H21BrN7O : Cl
Mol.Wt.
515.4 : 35.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Etravirine Impurity 22 is chemically 1-(6-Benzamido-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)-4-(dimethylamino)pyridin-1-ium chloride. Etravirine Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Etravirine Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Etravirine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Etravirine Impurity 22

Purchase Etravirine Impurity 22

Etravirine Impurity 22 suppliers

Etravirine Impurity 22 manufacturers

Etravirine Impurity 22 price

Order Etravirine Impurity 22

Enquire Etravirine Impurity 22

Etravirine Impurity 22 cost

Etravirine Impurity 22 Supplier

Etravirine Impurity 22 Distributor

Etravirine Impurity 22 for Method Validation

Etravirine Reference Standard

Etravirine Impurity 22 for ANDA Filing

Etravirine Impurity 22 for Forced Degradation Studies

Etravirine Impurity 22 Identification Standards

Etravirine Impurity 22 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,